Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapeutic update 1997-1998]

A J Scheen1

  • 1Département de Médecine, Université de Liège.

Revue Medicale De Liege
|December 3, 1998
PubMed
Summary
This summary is machine-generated.

This review covers new drugs for internal medicine in Belgium, focusing on infectious, rheumatoid, immunologic, oncologic, and urogenital diseases. It highlights novel molecules and their clinical application for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

Area of Science:

  • Internal Medicine
  • Pharmacology
  • Clinical Therapeutics

Context:

  • Overview of recent pharmaceutical advancements in Belgium.
  • Focus on drugs impacting infectious, rheumatoid, immunologic, oncologic, and urogenital conditions.
  • Emphasis on newly registered and launched medications within the past year.

Purpose:

  • To describe key new drugs in internal medicine.
  • To highlight the novelty and clinical utility of these pharmaceutical agents.
  • To provide guidance on appropriate use in clinical practice.

Summary:

  • Details on innovative molecules for treating infectious diseases.
  • Review of new treatments for rheumatoid and immunologic disorders.
  • Exploration of emerging oncologic and urogenital therapies.

Related Experiment Videos

Impact:

  • Informing clinicians about the latest therapeutic options.
  • Facilitating evidence-based prescribing of new medications.
  • Enhancing patient care through access to novel treatments.